Influenza medicines made by Fujifilm cure Ebola

A drug of Fujifilm, called Favipiravir, has gained worldwide attention after curing Ebola for a French nurse on October 4. This is considered the leading candidate for a drug that can effectively treat Ebola. According to information from Fujifilm, the French government and West African nations will also consider testing the drug for Ebola-infected patients in the coming November.

Favipiravir is a flu medication that has been studied and prepared by Toyama Chemical, a subsidiary of Fujifilm. The drug has been licensed for circulation by the Ministry of Health, Labor and Welfare of Japan since March 2014. According to Fujifilm's statement, a French nurse infected with the Ebola virus was treated with Favipiravir. along with some other drugs. Until the beginning of October, the nurse recovered and was allowed to leave the hospital. In Germany, an Ebola patient has also been reported to have recovered due to the same treatment.

Fujifilm added that currently, some countries and organizations around the world have also contacted the firm to test drugs for Ebola patients. Yoshihide Suga, a spokesman for the Japanese government, said: "Japan is ready to provide experimental drugs to Ebola patients as soon as the WHO health organization requests it. At the same time, Japan is also ready to supply drugs. For any unilateral suggestions from countries around the world if you meet certain conditions in an emergency ".

According to the report, the upcoming pharmaceutical company MediVector, a partner of Fujifim in the US, will also propose to the US Food and Drug Administration to conduct a trial of the drug to treat Ebola. Until now, WHO reported that a total of 7470 cases were found to be infected with Ebola and 3431 died from the disease. Another information is that since the publication of the drug, the trading value of Fujifim shares on the Tokyo Stock Exchange has increased dramatically, the highest increase in the last 6 years from September 2009.